VITAstir Review: Homekit Prices and Refill Terms

The useful comparison at VITAstir is four injections against four injections. Its catalog includes Homekits and separate SDV listings with different quantities and conflicting price displays. A $99 listing is not enough to budget for a month of treatment. We would request a written product, quantity and renewal quote before choosing this service.

We have not used VITAstir's treatment. The public product and policy pages support a purchasing comparison; they do not establish a personal prescription, clinical outcome or completed invoice.

The semaglutide starting prices describe different offers

The main semaglutide Homekit page lists $125 for four injections at its starting strength, with higher listed charges as the prescribed strength increases. Its descriptions refer to semaglutide with B12, physician access, syringes and alcohol pads. That is more informative than a starting price alone, but it is still an advertisement rather than your selected bill.

The separate semaglutide SDV page displays $99 and describes a one-week supply. Within that same page, a one-injection line says $69 while another says $99; its first four-injection package is listed at $185 in one section and $135 in another. Those are discrepancies to resolve, not numbers to average. Ask which listing and quantity you are being offered.

The main page also uses different upper-strength figures in its overview and price ladder. We would have the prescribing clinician and dispensing pharmacy confirm the exact preparation and label. A product page's ladder is not a schedule for changing your own dose.

Tirzepatide also needs a quantity-specific quote

The main tirzepatide Homekit lists $145 for four starting-strength injections and increases through a $599 four-injection listing. It describes tirzepatide with glycine and B12, supplies and physician access. The lowest charge therefore does not establish the price at every strength.

Its separate SDV page displays $99 for a one-week listing, while the first four-week package appears at $225 in one section and $189 in another. Its procedure and frequency passages also describe administration differently. Get one set of pharmacy instructions for the actual prescription; do not resolve contradictory website directions yourself.

These are separate compounded preparations. We did not establish that their additives improve tolerability, preserve muscle or make them equivalent to a branded product. Our compounded-versus-brand guide explains the product distinction. A familiar ingredient name does not settle the preparation or its clinical suitability.

A refill can be billed before a calendar month ends

The refund policy says recurring subscriptions bill every 25 days and require cancellation before the next billing. Once that charge occurs, the policy says it cannot be canceled or refunded. This is a recurring-payment boundary, not proof that every Homekit is sold as a subscription or that every shipment arrives on that same cycle.

Before agreeing to recurring payments, request the first charge, next charge date, number of injections and delivery schedule together. Our four-week versus monthly billing guide explains why supply, billing and calendar months must be compared separately. We would not multiply an unresolved starting price by six and call it a six-month cost.

The declined-prescription promise needs a specific answer

The general refund page describes products and Homekits as nonrefundable. The product pages separately promise a refund if the physician does not approve treatment. That distinction matters before paying: ask how clinical rejection is handled and which part of the payment is returned. It does not establish a refundable trial after medication is approved or received.

The FAQ requires delivery or product problems to be reported within 48 hours of receipt. That reporting window is not the same as an unconditional refund entitlement. Keep the order details and ask what happens to a damaged, incorrect or delayed prescription.

Physician access is not a complete monitoring plan

The Homekit offers include physician access and describe possible contact after purchase if more information is needed. Those statements do not establish a scheduled consultation, particular laboratory panel, response-time guarantee or continuing monitoring arrangement. Request those details for your prescription rather than assume they are part of every advertised kit.

The terms identify The Healthy Life Company USA, LLC doing business as VitaStir as the platform and describe contracted physicians and pharmacies as responsible for their professional services. This identifies a platform relationship; it does not establish the clinician, contracting practice or dispenser assigned to you. We did not verify those individual assignments or a complete product-specific state map.

Check the exact dispensing pharmacy

The Pharmacies & Labs page describes PCAB-accredited pharmacy partners and 503B manufacturers. Its general partner description does not identify a dispenser for a particular order. We did not independently verify your assigned pharmacy's current license, accreditation scope or authorization to dispense this preparation to your state.

Ask for the dispensing name and address, then use our pharmacy verification guide. Neither a general accreditation claim nor a badge establishes approval of a compounded product or the outcome of its treatment. The clinician and pharmacy should also explain the actual label, storage and usable duration; broad website shipping statements are not a substitute.

Check the paperwork before using a benefits card

The FAQ says insurance is not accepted. It accepts HSA/FSA cards but says it supplies an ordinary receipt and does not provide additional forms, codes or physician notes if the account requires them. Card acceptance and the paperwork needed by your account are separate questions. Confirm the documentation with the administrator before relying on that payment route.

The HSA/FSA guide helps organize those questions. This review does not determine reimbursement, tax eligibility or a personal benefit entitlement.

Our recommendation: settle the kit and contract first

VITAstir gives a shopper several visible product and strength listings to compare. Our reservation is the mismatch between low SDV headlines, four-injection packages and different figures within individual pages. The purchase decision should wait until the seller can identify one preparation, quantity, total charge and recurring schedule consistently.

We would consider it only after those answers, an assigned care team and pharmacy, and the rejection/refund boundary are clear. Someone who needs a settled ongoing price before sharing medical information may prefer a service with a more consistent public offer. Compare provider reviews and the provider-selection checklist using the same prescribed product and quantity.